- Home
- ALGS vs MNDO Comparison
ALGS vs MNDO Comparison
Compare ALGS & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- MNDO
- Stock Information
- Founded
- ALGS 2018
- MNDO 1995
- Country
- ALGS United States
- MNDO Israel
- Employees
- ALGS N/A
- MNDO N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- ALGS Health Care
- MNDO Technology
- Exchange
- ALGS Nasdaq
- MNDO Nasdaq
- Market Cap
- ALGS 32.4M
- MNDO 34.2M
- IPO Year
- ALGS 2020
- MNDO 2000
- Fundamental
- Price
- ALGS $5.56
- MNDO $1.48
- Analyst Decision
- ALGS Strong Buy
- MNDO
- Analyst Count
- ALGS 1
- MNDO 0
- Target Price
- ALGS $70.00
- MNDO N/A
- AVG Volume (30 Days)
- ALGS 152.4K
- MNDO 43.0K
- Earning Date
- ALGS 05-06-2025
- MNDO 05-06-2025
- Dividend Yield
- ALGS N/A
- MNDO 15.07%
- EPS Growth
- ALGS N/A
- MNDO N/A
- EPS
- ALGS N/A
- MNDO 0.17
- Revenue
- ALGS $3,270,000.00
- MNDO $20,677,000.00
- Revenue This Year
- ALGS $583.52
- MNDO N/A
- Revenue Next Year
- ALGS N/A
- MNDO N/A
- P/E Ratio
- ALGS N/A
- MNDO $8.61
- Revenue Growth
- ALGS N/A
- MNDO N/A
- 52 Week Low
- ALGS $3.76
- MNDO $1.43
- 52 Week High
- ALGS $46.80
- MNDO $2.13
- Technical
- Relative Strength Index (RSI)
- ALGS 46.04
- MNDO 31.76
- Support Level
- ALGS $4.20
- MNDO $1.34
- Resistance Level
- ALGS $6.45
- MNDO $1.49
- Average True Range (ATR)
- ALGS 0.72
- MNDO 0.05
- MACD
- ALGS 0.34
- MNDO -0.01
- Stochastic Oscillator
- ALGS 60.44
- MNDO 40.00
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.